A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants

被引:20
|
作者
Li, Xuanyi [1 ]
Warner, Jeremy L. [2 ,3 ]
机构
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA
[3] Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2020年 / 8卷
关键词
precision oncology; knowledgebase; variant interpretation; actionability; targeted therapy; genotype-selective clinical trial; tumor genetic testing; OFF-LABEL USE; PRIVATE MUTATIONS; PHARMACOGENOMICS KNOWLEDGE; MEDICINE; GENOMICS; TRIAL; IDENTIFICATION; INFORMATION; PREVALENCE; LANDSCAPE;
D O I
10.3389/fcell.2020.00048
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The increased availability of tumor genetic testing and targeted cancer therapies contributes to the advancement of precision medicine in the field of oncology. Precision oncology knowledgebases provide a way of organizing clinically relevant genetic information in a way that is easily accessible for both oncologists and patients, facilitating the genetic-based clinical decision making. Many organizations and companies have built precision oncology knowledgebases, intended for multiple users. In general, these knowledgebases offer information on cancer-related genetic variants as well as their associated diagnostic, prognostic, and therapeutic implications, but they often differ in their information curations, designs, and user experiences. It is advisable that oncologists use multiple knowledgebases during their practice to have them complement each other. In the future, convergence toward common standards and formats is needed to ensure that the comprehensive knowledge across all sources can be unified to bring the oncology community closer to the achievement of the goal of precision oncology.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Assessing actionability and incidental findings of germline variants in two precision oncology trials
    Ibrahim, Maria Baz
    Adnani, Yahia
    Clement, Gerome Jules
    Lacroix, Ludovic
    Loriot, Yohann
    Besse, Benjamin
    Massard, Christophe
    Rouleau, Etienne
    EUROPEAN JOURNAL OF CANCER, 2024, 210
  • [2] Bioinformatics workflows for clinical applications in precision oncology
    Jaeger, Natalie
    SEMINARS IN CANCER BIOLOGY, 2022, 84 : 103 - 112
  • [3] Precision oncology for gallbladder cancer: insights from genetic alterations and clinical practice
    Lin, Jianzhen
    Dong, Kun
    Bai, Yi
    Zhao, Songhui
    Dong, Yonghong
    Shi, Junping
    Shi, Weiwei
    Long, Junyu
    Yang, Xu
    Wang, Dongxu
    Yang, Xiaobo
    Zhao, Lin
    Hu, Ke
    Pan, Jie
    Sang, Xinting
    Wang, Kai
    Zhao, Haitao
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (18)
  • [4] Automatic Extraction of Genomic Variants for Locating Precision Oncology Clinical Trials
    Chen, Hui
    Xiaoyuan, Huyan
    Hu, Danqing
    Duan, Huilong
    Lu, Xudong
    HEALTH INFORMATION PROCESSING, CHIP 2022, 2023, 1772 : 109 - 123
  • [5] Resources for Interpreting Variants in Precision Genomic Oncology Applications
    Tsang, Hsinyi
    Addepalli, KanakaDurga
    Davis, Sean R.
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [6] Clinical Actionability of Genetic Findings in Cerebral Palsy: A Systematic Review and Meta-Analysis
    Lewis, Sara A.
    Chopra, Maya
    Cohen, Julie S.
    Bain, Jennifer M.
    Aravamuthan, Bhooma
    Carmel, Jason B.
    Fahey, Michael C.
    Segel, Reeval
    Wintle, Richard F.
    Zech, Michael
    May, Halie
    Haque, Nahla
    Fehlings, Darcy
    Srivastava, Siddharth
    Kruer, Michael C.
    JAMA PEDIATRICS, 2025, 179 (02) : 137 - 144
  • [7] Precision oncology: a clinical and patient perspective
    Lassen, Ulrik N.
    Makaroff, Lydia E.
    Stenzinger, Albrecht
    Italiano, Antoine
    Vassal, Gilles
    Garcia-Foncillas, Jesus
    Avouac, Bernard
    FUTURE ONCOLOGY, 2021, 17 (30) : 3995 - 4009
  • [8] Clinical utility of whole-genome sequencing in precision oncology
    Rosenquist, Richard
    Cuppen, Edwin
    Buettner, Reinhard
    Caldas, Carlos
    Dreau, Helene
    Elemento, Olivier
    Frederix, Geert
    Grimmond, Sean
    Haferlach, Torsten
    Jobanputra, Vaidehi
    Meggendorfer, Manja
    Mullighan, Charles G.
    Wordsworth, Sarah
    Schuh, Anna
    SEMINARS IN CANCER BIOLOGY, 2022, 84 : 32 - 39
  • [9] The Challenge of Genetic Variants of Uncertain Clinical Significance A Narrative Review
    Burke, Wylie
    Parens, Erik
    Chung, Wendy K.
    Berger, Sara M.
    Appelbaum, Paul S.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (07) : 994 - +
  • [10] Precision oncology for intrahepatic cholangiocarcinoma in clinical practice
    Tomczak, Aurelie
    Springfeld, Christoph
    Dill, Michael T.
    Chang, De-Hua
    Kazdal, Daniel
    Wagner, Ursula
    Mehrabi, Arianeb
    Brockschmidt, Antje
    Luedde, Tom
    Naumann, Patrick
    Stenzinger, Albrecht
    Schirmacher, Peter
    Longerich, Thomas
    BRITISH JOURNAL OF CANCER, 2022, 127 (09) : 1701 - 1708